{"meta":{"query_hash":"a36e830bb1f5","filters":{"venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a36e830bb1f5","api":"https://metacan.xera.ac/api/v1/cohort?venue=Applied+Clinical+Research+Clinical+Trials+and+Regulatory+Affairs"},"results":[{"id":"W2757851334","doi":"10.2174/2213476x03666160112001136","title":"Product Life Cycle Management for Pharmaceutical Innovation","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scrutiny; Commercialization; Product lifecycle; Business; Product (mathematics); New product development; Scope (computer science); Biosimilar; Product life-cycle management; Phase (matter); Competition (biology); Pharmaceutical industry; Marketing; Industrial organization; Computer science","score_opus":0.6685465453233798,"score_gpt":0.6240170960708625,"score_spread":0.04452944925251723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757851334","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019135207,0.029504068,0.76786697,0.009347679,0.0009896737,0.0024933442,0.0027177655,0.0033765254,0.16456881],"genre_scores_gemma":[0.48722118,0.01915055,0.45028114,0.0015619016,0.0006387526,0.002646035,0.004645577,0.00064784073,0.03320703],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99406517,0.0018297564,0.00037921753,0.00087833876,0.0025317068,0.00031586617],"domain_scores_gemma":[0.9898051,0.0037280591,0.001677046,0.0011324779,0.0033342517,0.00032307827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007628419,0.0012127743,0.0007919778,0.0030590496,0.0010522096,0.0057045897,0.0018575911,0.0013474213,0.015067631],"category_scores_gemma":[0.01763003,0.0004732607,0.0012184724,0.003605137,0.0014219554,0.0043801735,0.0024472275,0.0016172042,0.0041683773],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019836778,0.0001580172,0.003480957,0.0021667504,0.0000781181,0.00011930084,0.0004332515,0.050143827,0.002112024,0.22850691,0.029964829,0.6826377],"study_design_scores_gemma":[0.00008532751,0.00060181494,0.0042949505,0.0020300634,0.00015210468,0.00027550667,0.000767758,0.19534649,0.007794584,0.34663635,0.441856,0.0001591188],"about_ca_topic_score_codex":0.0031785818,"about_ca_topic_score_gemma":0.0018074551,"teacher_disagreement_score":0.015067631,"about_ca_system_score_codex":0.00566466,"about_ca_system_score_gemma":0.0064978697,"threshold_uncertainty_score":0.050406277},"labels":[],"label_agreement":null},{"id":"W2759170843","doi":"10.2174/2213476x03666151221210747","title":"Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Biopharmaceutical; Medicine; Business; Risk analysis (engineering); Biotechnology","score_opus":0.7556914656993441,"score_gpt":0.5835080839316263,"score_spread":0.17218338176771775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759170843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025885636,0.7696208,0.008802421,0.13353229,0.009209906,0.00026754048,0.0007976447,0.00039040082,0.07479043],"genre_scores_gemma":[0.02969773,0.8379836,0.014501934,0.08770169,0.009225492,0.0004548394,0.0017867894,0.00018723375,0.018460752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99226576,0.0018993827,0.0009541619,0.00095788314,0.0031768489,0.0007460048],"domain_scores_gemma":[0.9860821,0.004749469,0.0018987288,0.00035967084,0.0058277454,0.0010822552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012551673,0.0011452122,0.0012122708,0.0021483165,0.0012197184,0.007101863,0.0025331995,0.010678771,0.013792277],"category_scores_gemma":[0.015216835,0.0005122774,0.0017296615,0.0028273303,0.0022799042,0.009273878,0.0021752673,0.008402117,0.004407062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023841094,0.00019769854,0.00086898886,0.008830384,0.0000731927,0.0007948309,0.00044335597,0.0012603106,0.0049077906,0.15715602,0.20396693,0.6212621],"study_design_scores_gemma":[0.000023821776,0.00013659404,0.00039579795,0.0028526264,0.00004274263,0.00059821754,0.00016338036,0.00029460873,0.00075015944,0.016472021,0.9782413,0.00002867941],"about_ca_topic_score_codex":0.002928593,"about_ca_topic_score_gemma":0.0018490991,"teacher_disagreement_score":0.013792277,"about_ca_system_score_codex":0.0038039773,"about_ca_system_score_gemma":0.012961123,"threshold_uncertainty_score":0.06638044},"labels":[],"label_agreement":null},{"id":"W2766000227","doi":"10.2174/2213476x03666160127001910","title":"Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Probiotic; Context (archaeology); Good manufacturing practice; Business; Quality (philosophy); Scopus; Product (mathematics); Risk analysis (engineering); Control (management); Marketing; MEDLINE; Computer science; Political science; Supply chain; Biology","score_opus":0.6378639548133486,"score_gpt":0.5791816973261519,"score_spread":0.05868225748719669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766000227","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006952021,0.236105,0.02381828,0.6337015,0.014878747,0.0014915471,0.0015146522,0.0008347553,0.080703475],"genre_scores_gemma":[0.104034625,0.39579323,0.17572962,0.2727444,0.00766035,0.002784288,0.0031537933,0.00046357093,0.037636116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9479297,0.015263023,0.00875018,0.0029740697,0.022868916,0.0022141503],"domain_scores_gemma":[0.880514,0.05140324,0.013407731,0.00595998,0.045895014,0.002819979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041900385,0.0012391619,0.0012607913,0.004228691,0.0024852147,0.010687499,0.0050359746,0.013543617,0.0064114197],"category_scores_gemma":[0.08120669,0.00073860167,0.0018843468,0.004963422,0.006798137,0.009625426,0.0033909064,0.011421564,0.003986206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029691897,0.00068220444,0.0034223727,0.025466403,0.00011884509,0.0019177581,0.0045337216,0.0015444289,0.00900033,0.18290533,0.36256108,0.40755063],"study_design_scores_gemma":[0.000024125527,0.00015128046,0.0027383873,0.019626455,0.00011392196,0.00065572385,0.0035166198,0.0003683065,0.0019702346,0.023570707,0.9471551,0.000109214474],"about_ca_topic_score_codex":0.008507505,"about_ca_topic_score_gemma":0.008106185,"teacher_disagreement_score":0.041900385,"about_ca_system_score_codex":0.0058819163,"about_ca_system_score_gemma":0.04158923,"threshold_uncertainty_score":0.22159302},"labels":[],"label_agreement":null},{"id":"W2804493567","doi":"10.2174/2213476x03666151125220117","title":"Regulations of Cosmetics Across the Globe","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cosmetics; European union; Legislature; Business; Legislation; Political science; Medicine; Law; International trade","score_opus":0.543522808613697,"score_gpt":0.5977178971760421,"score_spread":0.05419508856234512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804493567","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010628579,0.29504725,0.008643129,0.047819585,0.0057249973,0.0015456395,0.014955287,0.0008902238,0.6147453],"genre_scores_gemma":[0.17346203,0.518675,0.03543988,0.095411144,0.0021370873,0.0035667154,0.02167959,0.0010348761,0.14859362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97599036,0.003951743,0.003580213,0.0018990084,0.013552363,0.0010263041],"domain_scores_gemma":[0.9502955,0.014476973,0.0077021252,0.0028111578,0.023757508,0.0009568645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010841778,0.0006360533,0.0007572341,0.005367523,0.0018194554,0.0045230654,0.0022268973,0.0033707204,0.018942438],"category_scores_gemma":[0.028089194,0.00045061894,0.0011720994,0.008107484,0.0030861117,0.0022531524,0.002168509,0.0028258143,0.0061703078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014880674,0.00011739115,0.004018543,0.024433352,0.00009161441,0.0011647333,0.0036419546,0.00066662184,0.006312999,0.11655967,0.3911673,0.45167693],"study_design_scores_gemma":[0.0000055349556,0.000014513795,0.0025471933,0.0048412387,0.000030145959,0.00021121647,0.0002877825,0.000021603806,0.0006590197,0.0012333844,0.99013126,0.000017056573],"about_ca_topic_score_codex":0.06434952,"about_ca_topic_score_gemma":0.0465909,"teacher_disagreement_score":0.06434952,"about_ca_system_score_codex":0.0064224005,"about_ca_system_score_gemma":0.03331535,"threshold_uncertainty_score":0.12794995},"labels":[],"label_agreement":null}]}